Bicarbonate

Bicarbonate

SCHEMBL18280949

O=C([O-])[O-].[Ag+].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL1291 0.94
Bicarbonate SCHEMBL1330785 0.94
Bicarbonate SCHEMBL26137 0.94
Bicarbonate SCHEMBL1908265 0.94
Bicarbonate SCHEMBL23849739 0.88 CA4 (0.60)
Bicarbonate SCHEMBL57315 0.88
Bicarbonate SCHEMBL224668 0.88
Bicarbonate SCHEMBL3503293 0.88
Bicarbonate SCHEMBL1700772 0.88
Bicarbonate SCHEMBL18420858 0.88 CA4 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260027072-A1 COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT LPOXY THERAPEUTICS INC (US) 2026-01-29 US disclosed
US-20220331355-A1 PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA LPOXY THERAPEUTICS, INC. 2022-10-20 US disclosed
US-11311573-B2 Pharmaceutical preparations and methods to manage weight and to modulate the gut microbiota XENO BIOSCIENCES INC. (US) 2022-04-26 US disclosed
EP-3915552-A1 COMPOSITIONS FOR USE IN MODULATING THE GUT MICROBIOTA AND MANAGING WEIGHT Xeno Biosciences Inc. (US) 2021-12-01 EP disclosed
US-11179356-B2 Methods and compositions to modulate the gut microbiota and to manage weight XENO BIOSCIENCES INC. (US) 2021-11-23 US disclosed
US-11179357-B2 Methods and compositions to modulate the gut microbiota and to manage weight XENO BIOSCIENCES INC. (US) 2021-11-23 US disclosed
US-20210177784-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT LPOXY THERAPEUTICS, INC. 2021-06-17 US disclosed
US-20210169829-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT LPOXY THERAPEUTICS, INC. 2021-06-10 US disclosed
US-20210161839-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT LPOXY THERAPEUTICS, INC. 2021-06-03 US disclosed
US-10945974-B2 Methods and compositions to modulate the gut microbiota and to manage weight XENO BIOSCIENCES INC. (US) 2021-03-16 US disclosed
US-20200078397-A1 PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA XENO BIOSCIENCES INC. (US) 2020-03-12 US disclosed
EP-3548008-A1 PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA Xeno Biosciences Inc. (US) 2019-10-09 EP disclosed
WO-2018102469-A1 PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA XENO BIOSCIENCES INC. (US) 2018-06-07 WO disclosed
US-20180147167-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT XENO BIOSCIENCES INC. (US) 2018-05-31 US disclosed
EP-3302703-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT Xeno Biosciences Inc. (US) 2018-04-11 EP disclosed
WO-2016196440-A1 METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT XENO BIOSCIENCES INC. (US) 2016-12-08 WO disclosed